Académique Documents
Professionnel Documents
Culture Documents
la
i-
la
as TEMA MONOGRFICO
co DEMENCIA: UNA EPIDEMIA EN EL SIGLO XXI
a;
ESTUDIOS GENTICOS
CONCLUSIN
(1316)
01 TMDemencias 6418 15/10/04 09:43 Pgina 3
Bibliografa
1. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kom-
men E. Mild cognitive impairment: clinical characterization and out-
come. Archives of Neurology 1999;56:303-8.
2. Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings JL,
DeKosky ST. Practice parameter: early detection of dementia: mild
cognitive impairment (an evidence-based review). Neurology
2001;56:1133-42.
3. Ritchie K, Touchon J. Mild cognitive impairment: conceptual basis
and current nosological status. Lancet 2000;355:225-8.
4. Convit A, De Asis J, De Leon MJ, Tarshish CY, De Santi S, Rusinek
H. Atrophy of the medial occipitotemporal, inferior, and middle tem-
poral gyri in non-demented elderly predict decline to Alzheimers di-
sease. Neurobiol Aging 2000;21:19-26.
5. Valenzuela M, Sachdev P. Magnetic resonance spectroscopy in AD.
Neurology 2001;56:592-8.
6. Schuff N, Amend DL, Ezekiel F, et al. Changes of hippocampal N-
acetylaspartate and volume in Alzheimers disease: a proton MR spec-
troscopic imaging and MRI study. Neurology 1997;49:1513-21.
7. Kantarci K, Smith GE, Petersen RC, Boeve BF, Knopman DS, Tan-
galos EG, et al. 1H magnetic resonance spectroscopy, cognitive func-
tion, and apolipoprotein E, genotype in normal aging, mild cognitive
impairment and Alzheimers disease. J Intern Neuropsychol Soc
2002;8:934-42.
8. Catani M, Cherubini A, Howard R, Tarducci R, Pelliccioli G, Piccirili
M, et al. 1H-MR spectroscopy differentiates mild cognitive impair-
ment from normal brain aging. Neuroreport 2001;12:2315-7.
9. Nestor PJ, Fryer TD, Smielewski P, Hodges JR. Limbic hypometabo-
lism in Alzheimers Disease and mild cognitive impairment. Ann Neu-
rol 2003;54:343-51.
10. Ghebremedhin E, Schultz C, Thal DR, Ohm TG, Braak E, Braak K.
Gender and age modify the association between APOE and AD-rela-
ted neuropathology. Neurology 2001;56:1696-701.
11. Smith GE, Bohac DL, Waring SC, Kokmen E, Tangalos EG, Ivnik RJ,
et al. Apopliprotein E genotype influences cognitive phenotype in
patients with Alzheimers disease but not in healthy control subjects.
Neurology 1998; 50:355-62.
(1317)